PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2011

Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 21372687 ↗2011Reported benefit

Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis.

RatIschaemia-reperfusionOther / unspecifiedSprague-DawleyMaletopical shock wave0.1 mJ/mm2, 5 impulses/s, 300 impulsespre-, immediately and 24 h post-ischaemic insult

Model: ischaemic epigastric skin flap

ESWT improved flap perfusion, microvessel number and survival through neovascularisation irrespective of application timing.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.